- Fund Type: SICAV
- Objective: Growth
- Asset Class: Equity
- Geographic Focus: Spain
Eikon 99 SICAV SA
+ Add to WatchlistS0857:SM
44.1700 EUR 0.3100 0.71%As of 10:00:26 ET on 06/19/2013.
Snapshot for Eikon 99 SICAV SA (S0857)
| Open: | 44.1700 | High - Low: | 44.1700 - 44.1700 | Primary Exchange: | Continuous |
|---|---|---|---|---|---|
| Volume: | 0 | 52-Week Range: | 27.6600 - 45.2700 | Beta vs IBEX: | 0.8950 |
Fund Profile & Information for S0857
Eikon 99 SICAV SA is an open-end investment company incorporated in Spain. The investment company's objective is capital growth. It primarily invests in equity securities.
| Inception Date: | 2006-12-19 | Telephone: | - |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | www.bbva.es | ||
Fundamentals for S0857
| NAV | (on 2013-06-18) 44.1742 |
|---|---|
| Assets (M) | (on 2013-04-04) 5.4958 |
| Shares out (M) | 0.00 |
| Market Cap (M) | 0.00 |
| % Premium | -0.71 |
| Average 52-Week % Premium | -0.1371 |
| Fund Leveraged | N |
Dividends for S0857
No dividends reported
Performance for S0857
| 1-Month | +0.53% | 1-Year | +40.89% |
|---|---|---|---|
| 3-Month | +4.45% | 3-Year | +1.35% |
| Year To Date | +9.29% | 5-Year | +8.16% |
| Expense Ratio | - |
Top Fund Holdings for S0857
Filing Date: 02/29/2012| Name | Position | Value | % of Total |
|---|---|---|---|
| SPGB Float 10/29/12 | 1,959 | 1,962,376 | 21.051% |
| Banco Santander SA | 104,258 | 649,215 | 6.964% |
| AXA SA | 50,000 | 605,250 | 6.493% |
| Aegon NV | 150,000 | 589,500 | 6.324% |
| ING Groep NV | 77,000 | 512,666 | 5.499% |
| Societe Generale SA | 20,000 | 485,000 | 5.203% |
| Gamesa Corp Tecnologica SA | 200,000 | 477,200 | 5.119% |
| Banco Bilbao Vizcaya Argentari | 62,124 | 418,032 | 4.484% |
| Repsol SA | 20,000 | 391,400 | 4.199% |
| Telefonica SA | 30,000 | 384,300 | 4.122% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page